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Abstract
© The Author 2015. Published by Oxford University Press on behalf of the European Association
for Cardio-Thoracic Surgery. All rights reserved. OBJECTIVES: Remote ischaemic preconditioning
(RIPC) is a non-invasive and virtually cost-free strategy for protecting the heart against acute
ischaemia-reperfusion injury (IRI). We have recently shown that the inhibition of extracellular
RNA (eRNA) using non-toxic RNase1 protected the heart against acute IRI, reduced myocardial
infarct (MI) size and preserved left ventricular systolic function in rodent animal MI models.
Based on this previous work in animals, the role of the eRNA/RNase1 system in cardiac RIPC in
humans should be defined. METHODS: Fourteen patients underwent cardiac surgery without
RIPC; from each patient, six separate 5 ml blood specimens from radial artery and two blood
specimens from coronary sinus at different time points during heart surgery were taken. Six
healthy  donors  received RIPC (4  × 5  min  upper  limb ischaemia);  blood  parameters  were
quantified before and after RIPC. Twelve patients underwent cardiac surgery of which 6 received
RIPC,  whereas  the  remaining  6  were  exposed  to  sham procedure.  Circulating  eRNA  was
quantified in plasma from arterial and coronary sinus blood obtained from patients undergoing
cardiac by standard procedures. Tumour necrosis factor-α (TNF-α) production by heart tissue
was assessed by enzyme-linked immuno-sorbent assay; RNase activity was quantified by an
enzymatic assay. RESULTS: Before surgery, eRNA levels were similar in both groups (14 ± 6 vs
13 ± 5 ng/ml; P = 0.9967). In patients without RIPC, arterial eRNA levels rose during surgery (87
± 12 ng/ml) and peaked after (127 ± 11 ng/ml) aortic declamping; accordingly, eRNA levels in
coronary sinus blood were significantly higher (206 ± 32 ng/ml; P = 0.0129) than that in radial
artery. Moreover,  significant elevation of TNF-α (36 ± 6 ng/ml;  P = 0.0059) particularly in
coronary sinus blood after opening of the aortic clamping was observed. Interestingly, applying
a RIPC protocol significantly increased levels of plasma endogenous vascular RNase1 by >7-fold,
and the levels of arterial (31 ± 7 ng/ml; P = 0.0024) and coronary sinus (37 ± 9 ng/ml; P <
0.0001) circulating eRNA, as well as circulating TNF-α (20 ± 4 ng/ml; P = 0.0050) levels were
significantly reduced. CONCLUSIONS: Upon RIPC, the level of cardioprotective RNase1 increased,
while the concentration of damaging eRNA and TNF-α decreased. The present findings imply a
significant contribution of the RIPC-dependent (endothelial) RNase1 for improving the outcome
of cardiac surgery. However, the exact mechanism of RNase1-induced cardioprotection still
remains to be explored.
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